Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children

British Journal of Haematology

Volumn 136, Issue 2, 2007, Pages 297-300

  Sadakane, Y ^a   Zaitsu, M ^a   Nishi, M ^a   Sugita, K ^b   Mizutani, S ^c   Matsuzaki, A ^d   Sueoka, E ^a   Hamasaki, Y ^a   Ishii, E ^a  

^a SAGA UNIVERSITY   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Acute lymphoblastic leukaemia; BLNK; Children; Pax5

Indexed keywords

TRANSCRIPTION FACTOR PAX5;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INFANT; NEWBORN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN VARIANT; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; B-CELL-SPECIFIC ACTIVATOR PROTEIN; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EXONS; GENE DELETION; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; RNA, MESSENGER;

EID: 33845894451     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06425.x     Document Type: Article

References (8)

1. Borson, N.D., Lacy, M.Q. & Wettstein, P.J. (2002) Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma. Blood, 100, 4629-4639.
2. Dorfler, P. & Busslinger, M. (1996) C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8. The EMBO Journal, 15, 1971-1982.
3. Horcher, M., Souabni, A. & Busslinger, M. (2001) Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity, 14, 779-790.
4. Oppezzo, P., Dumas, G., Lalanne, A.I., Payelle-Brogard, B., Magnac, C., Pritsch, O., Dighiero, G. & Vuillier, F. (2005) Different isoforms of BSAP regulates of AID in normal and chronic lymphocytic leukemia B cells. Blood, 105, 2495-2503.
5. Robichaud, G.A., Nardini, M., Laflamme, M., Cuperlovic-Culf, M. & Ouellette, R.J. (2004) Human Pax5-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells. The Journal of Biological Chemistry, 279, 49956-49963.
6. + B-cell progenitors: single-cell analyses of their gene expression profiles. Blood, 101, 3424-3430.
7. Schebesta, M., Heavey, B. & Busslinger, M. (2002) Transcriptional control of B-cell development. Current Opinion in Immunology, 14, 216-223.
8. Tiacci, E., Pileri, S., Orleth, A., Pacini, R., Tabarrini, A., Frenguelli, F., Liso, A., Diverio, D., Lo-Coco, F. & Falini, B. (2004) PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. Cancer Research, 64, 7399-7404.